Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 4;11(9):1309. doi: 10.3390/biom11091309

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Variation in platelet characteristics in ESRD patients and healthy subjects (CTLs). (a) Percentage of ROS+ platelets (iROS). (b) Percentage of CD62P+-platelets. (c) Percentage of CD62P+/AnnV+ platelets. (d) Representative FACS plots of AnnV-PE and CD62P-APC labeled platelets from ESRD patients, before and after dialysis session, and healthy subjects. PRE, POST: ESRD patients pre-HD and post-HD, respectively (*) p < 0.05 vs. controls (**) p < 0.01 vs. controls, (#) p < 0.01 pre- vs. post-HD.